TEST BANK− ADVANCED PHARMACOLOGY FOR PRESCRIBERS – A
COMPREHENSIVE AND EVIDENCE-BASED PHARMACOLOGY REFERENCE BOOK
FOR ADVANCED PRACTICE STUDENTS AND CLINICIANS 1ST EDITION BY BRENT
LUU, GERALD KAYINGO, VIRGINIA MCCOY HASS| ALL CHAPTERS COVERED|
VERIFIED QUESTIONS & ANSWERS WITH RATIONALES| LATEST UPDATE
,Table of Contents
PART I: FOUNDATIONS OF PHARMACOLOGY AND PRESCRIBING .............................................................. 3
Chapter 1: An Introduction To Evidence-Based Clinical Practice Guidelines............................................ 3
Chapter 2: Pharmacokinetics .................................................................................................................. 14
Chapter 3: Pharmacodynamics ............................................................................................................... 25
Chapter 4: Pharmacogenetics And Pharmacogenomics ......................................................................... 30
Chapter 5: Pharmacology Across The Life Span...................................................................................... 34
Chapter 6: Drug-Therapy Prescribing In Special Populations ................................................................. 41
Chapter 7: Drug Development And Approval ......................................................................................... 47
Chapter 8: Foundations Of Prescription Writing .................................................................................... 53
Chapter 9: Responsible Controlled-Substance Prescribing..................................................................... 59
Chapter 10: Antibiotic Stewardship ........................................................................................................ 69
Chapter 11: Applied Calculations For Prescribing................................................................................... 80
Chapter 12: Promoting Adherence With Pharmacotherapy .................................................................. 86
PART II: SYSTEM-SPECIFIC AND PATIENT-FOCUSED PRESCRIBING ........................................................... 90
Chapter 13. Pharmacotherapy For Ear, Nose, Mouth, And Throat Conditions ...................................... 90
Chapter 14. Pharmacotherapy For Eye Conditions............................................................................... 110
Chapter 15: Pharmacotherapy For Skin Conditions .............................................................................. 118
Chapter 16: Pharmacotherapy For Neurologic Conditions ................................................................... 124
Chapter 17: Pharmacotherapy For Cardiovascular Conditions............................................................. 136
Chapter 18: Pharmacotherapy For Respiratory Conditions .................................................................. 145
Chapter 19: Pharmacotherapy For Gastrointestinal Conditions And Conditions Requiring Nutritional
Support ................................................................................................................................................. 154
Chapter 20: Pharmacotherapy For Genitourinary Conditions .............................................................. 163
Chapter 21: Pharmacotherapy For Renal, Acid–Base, Fluid, And Electrolyte Disorders ...................... 168
Chapter 22: Pharmacotherapy For Musculoskeletal And Rheumatologic Conditions ......................... 180
Chapter 23: Therapeutic Applications Of Immunology And Vaccines .................................................. 189
Chapter 24: Pharmacotherapy For Endocrine Disorders ...................................................................... 193
Chapter 25: Pharmacotherapy For Hematologic Disorders .................................................................. 203
Chapter 26: Hematology/Oncology And Supportive Care For The Nononcologist .............................. 217
Chapter 27: Pharmacotherapy Related To Women’s Health Conditions ............................................. 222
Chapter 28: Pharmacotherapy Related To Men’s Health Conditions ................................................... 233
Chapter 29: Pharmacotherapy Related To Transgender Care .............................................................. 238
, Chapter 30: Antimicrobial Pharmacotherapy ....................................................................................... 243
Chapter 31: Antiretroviral Pharmacotherapy ....................................................................................... 252
Chapter 32: Psychopharmacology And Integrative Health: Combined Treatment Of Psychiatric And
Neurocognitive Conditions ................................................................................................................... 260
Chapter 33: Pharmacotherapy For Pain Management ......................................................................... 270
Chapter 34: Substance Use Disorder .................................................................................................... 278
PART III: HEALTH PROMOTION AND MAINTENANCE ............................................................................. 293
Chapter 35: Over-The-Counter Medications ........................................................................................ 293
Chapter 36: Pharmacotherapy For Obesity .......................................................................................... 301
PART I: FOUNDATIONS OF PHARMACOLOGY AND PRESCRIBING
Chapter 1: An Introduction To Evidence-Based Clinical Practice Guidelines
MULTIPLE CHOICE
• What Is The Primary Purpose Of The Nursing Assessment?
A. Identifying Underlying Pathologic Conditions
B. Assisting The Physician In Identifying Medical Conditions
C. Determining The Patients Mental Status
D. Exploring Patient Responses To Health Problems
ANSWER>> D
A Nursing Assessment Is Done To Identify The Patients Response To Health Problems. During The
Nursing Assessment Phase, A Comprehensive Information Base Is Developed Through A Physical
Examination, Nursing History, Medication History, And Professional Observation. Identifying Underlying
Pathologic Conditions And Assisting The Physician In Identifying Medical Conditions Is Not Part Of The
Nursing Process. Determining The Patients Mental Status Is One Part Of The Nursing Assessment, But It
Is Not The Primary Purpose.
DIF: Cognitive Level: Comprehension REF: Dm 36 OBJ: 1 | 3 TOP: Nursing Process Step: Assessment
MSC: NCLEX Client Needs Category: Health Promotion And Maintenance
, • What Is The Basis Of The NANDA I Taxonomy?
A. Functional Health Patterns
B. Human Response Patterns
C. Basic Human Needs
D. Pathophysiologic Needs
ANSWER>> B
The NANDA I Taxonomy Identifies Human Response Patterns. Functional Components Of Health
Patterns Are Limited To Activity, Fluid Volume, Nutrition, Self Care, And Sensory Perception. Basic
Human Needs Comprise Less Than Merely Health Patterns. Pathophysiologic Needs Are Not Part Of The
Scope Of NANDA I.
DIF: Cognitive Level: Knowledge REF: Pp. 37-38 OBJ: 5 TOP:
Nursing Process Step: Diagnosis
MSC: NCLEX Client Needs Category: Physiological Integrity
• Which Task Is Included In The Assessment Step Of The Nursing Process?
A. Establishing Patient Goals/Outcomes
B. Implementing The Nursing Care Plan (NCP)
C. Measuring Goal/Outcome Achievement
D. Collecting And Communicating Data
ANSWER>> D
Data Are Collected And Communicated In The Assessment Phase Of The Nursing Process. Establishing
Goals Is The Function Of Planning.
Implementing The NCP Is The Function Of Implementation. Measuring Outcome Achievement Is The
Function Of Evaluation.
DIF: Cognitive Level: Comprehension REF: Dm 36 OBJ: 2 | 3 TOP: Nursing Process Step: Assessment
COMPREHENSIVE AND EVIDENCE-BASED PHARMACOLOGY REFERENCE BOOK
FOR ADVANCED PRACTICE STUDENTS AND CLINICIANS 1ST EDITION BY BRENT
LUU, GERALD KAYINGO, VIRGINIA MCCOY HASS| ALL CHAPTERS COVERED|
VERIFIED QUESTIONS & ANSWERS WITH RATIONALES| LATEST UPDATE
,Table of Contents
PART I: FOUNDATIONS OF PHARMACOLOGY AND PRESCRIBING .............................................................. 3
Chapter 1: An Introduction To Evidence-Based Clinical Practice Guidelines............................................ 3
Chapter 2: Pharmacokinetics .................................................................................................................. 14
Chapter 3: Pharmacodynamics ............................................................................................................... 25
Chapter 4: Pharmacogenetics And Pharmacogenomics ......................................................................... 30
Chapter 5: Pharmacology Across The Life Span...................................................................................... 34
Chapter 6: Drug-Therapy Prescribing In Special Populations ................................................................. 41
Chapter 7: Drug Development And Approval ......................................................................................... 47
Chapter 8: Foundations Of Prescription Writing .................................................................................... 53
Chapter 9: Responsible Controlled-Substance Prescribing..................................................................... 59
Chapter 10: Antibiotic Stewardship ........................................................................................................ 69
Chapter 11: Applied Calculations For Prescribing................................................................................... 80
Chapter 12: Promoting Adherence With Pharmacotherapy .................................................................. 86
PART II: SYSTEM-SPECIFIC AND PATIENT-FOCUSED PRESCRIBING ........................................................... 90
Chapter 13. Pharmacotherapy For Ear, Nose, Mouth, And Throat Conditions ...................................... 90
Chapter 14. Pharmacotherapy For Eye Conditions............................................................................... 110
Chapter 15: Pharmacotherapy For Skin Conditions .............................................................................. 118
Chapter 16: Pharmacotherapy For Neurologic Conditions ................................................................... 124
Chapter 17: Pharmacotherapy For Cardiovascular Conditions............................................................. 136
Chapter 18: Pharmacotherapy For Respiratory Conditions .................................................................. 145
Chapter 19: Pharmacotherapy For Gastrointestinal Conditions And Conditions Requiring Nutritional
Support ................................................................................................................................................. 154
Chapter 20: Pharmacotherapy For Genitourinary Conditions .............................................................. 163
Chapter 21: Pharmacotherapy For Renal, Acid–Base, Fluid, And Electrolyte Disorders ...................... 168
Chapter 22: Pharmacotherapy For Musculoskeletal And Rheumatologic Conditions ......................... 180
Chapter 23: Therapeutic Applications Of Immunology And Vaccines .................................................. 189
Chapter 24: Pharmacotherapy For Endocrine Disorders ...................................................................... 193
Chapter 25: Pharmacotherapy For Hematologic Disorders .................................................................. 203
Chapter 26: Hematology/Oncology And Supportive Care For The Nononcologist .............................. 217
Chapter 27: Pharmacotherapy Related To Women’s Health Conditions ............................................. 222
Chapter 28: Pharmacotherapy Related To Men’s Health Conditions ................................................... 233
Chapter 29: Pharmacotherapy Related To Transgender Care .............................................................. 238
, Chapter 30: Antimicrobial Pharmacotherapy ....................................................................................... 243
Chapter 31: Antiretroviral Pharmacotherapy ....................................................................................... 252
Chapter 32: Psychopharmacology And Integrative Health: Combined Treatment Of Psychiatric And
Neurocognitive Conditions ................................................................................................................... 260
Chapter 33: Pharmacotherapy For Pain Management ......................................................................... 270
Chapter 34: Substance Use Disorder .................................................................................................... 278
PART III: HEALTH PROMOTION AND MAINTENANCE ............................................................................. 293
Chapter 35: Over-The-Counter Medications ........................................................................................ 293
Chapter 36: Pharmacotherapy For Obesity .......................................................................................... 301
PART I: FOUNDATIONS OF PHARMACOLOGY AND PRESCRIBING
Chapter 1: An Introduction To Evidence-Based Clinical Practice Guidelines
MULTIPLE CHOICE
• What Is The Primary Purpose Of The Nursing Assessment?
A. Identifying Underlying Pathologic Conditions
B. Assisting The Physician In Identifying Medical Conditions
C. Determining The Patients Mental Status
D. Exploring Patient Responses To Health Problems
ANSWER>> D
A Nursing Assessment Is Done To Identify The Patients Response To Health Problems. During The
Nursing Assessment Phase, A Comprehensive Information Base Is Developed Through A Physical
Examination, Nursing History, Medication History, And Professional Observation. Identifying Underlying
Pathologic Conditions And Assisting The Physician In Identifying Medical Conditions Is Not Part Of The
Nursing Process. Determining The Patients Mental Status Is One Part Of The Nursing Assessment, But It
Is Not The Primary Purpose.
DIF: Cognitive Level: Comprehension REF: Dm 36 OBJ: 1 | 3 TOP: Nursing Process Step: Assessment
MSC: NCLEX Client Needs Category: Health Promotion And Maintenance
, • What Is The Basis Of The NANDA I Taxonomy?
A. Functional Health Patterns
B. Human Response Patterns
C. Basic Human Needs
D. Pathophysiologic Needs
ANSWER>> B
The NANDA I Taxonomy Identifies Human Response Patterns. Functional Components Of Health
Patterns Are Limited To Activity, Fluid Volume, Nutrition, Self Care, And Sensory Perception. Basic
Human Needs Comprise Less Than Merely Health Patterns. Pathophysiologic Needs Are Not Part Of The
Scope Of NANDA I.
DIF: Cognitive Level: Knowledge REF: Pp. 37-38 OBJ: 5 TOP:
Nursing Process Step: Diagnosis
MSC: NCLEX Client Needs Category: Physiological Integrity
• Which Task Is Included In The Assessment Step Of The Nursing Process?
A. Establishing Patient Goals/Outcomes
B. Implementing The Nursing Care Plan (NCP)
C. Measuring Goal/Outcome Achievement
D. Collecting And Communicating Data
ANSWER>> D
Data Are Collected And Communicated In The Assessment Phase Of The Nursing Process. Establishing
Goals Is The Function Of Planning.
Implementing The NCP Is The Function Of Implementation. Measuring Outcome Achievement Is The
Function Of Evaluation.
DIF: Cognitive Level: Comprehension REF: Dm 36 OBJ: 2 | 3 TOP: Nursing Process Step: Assessment
